Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction-Reference-Cited by-同舟云学术

Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction

Published:2020-01-30 Issue:4 Volume:10 Page:552-567
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Singh Nathan,Lee Yong Gu,Shestova Olga,Ravikumar Pranali,Hayer Katharina E.^ORCID,Hong Seok Jae,Lu Xueqing Maggie,Pajarillo Raymone^ORCID,Agarwal Sangya^ORCID,Kuramitsu Shunichiro,Orlando Elena J.,Mueller Karen Thudium,Good Charly R.,Berger Shelley L.,Shalem Ophir,Weitzman Matthew D.^ORCID,Frey Noelle V.,Maude Shannon L.,Grupp Stephan A.,June Carl H.^ORCID,Gill Saar,Ruella Marco^ORCID

Funder

Society of Immunotherapy for Cancer Holbrook Kohrt Immunotherapy Translational Fellowship

Breakthrough Bike Challenge Buz Cooper Scholarship

NCI

American Society of Hematology Scholar Award

Mark Foundation ASPIRE award

University of Pennsylvania-Novartis Alliance

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracellular zinc protects tumours from T cell-mediated cytotoxicity;Cell Death & Differentiation;2024-09-11

2. Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies;Blood Reviews;2024-09

3. Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial;Nature Communications;2024-08-11

4. Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies;ImmunoTargets and Therapy;2024-08

5. Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies;Molecular Therapy;2024-08